Preliminary Safety and Efficacy of HG004 Gene Therapy Trial for Leber's Congenital Amaurosis Associated with Mutations in RPE65 Gene

被引：0
|
作者：
Fei, Ping [1 ]
Yang, Yuan [1 ]
Peng, Jie [1 ]
Zhang, Xiang [1 ]
Wang, Yanfei [2 ]
Zhang, Shuaishuai [2 ]
Yao, Xuan [2 ]
Luk, Alvin [3 ]
Yuan, Yiqun [2 ]
Zhao, Peiquan [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Shanghai, Peoples R China
[2] Huidagene Therapeut Co Ltd, Shanghai, Peoples R China
[3] Huidagene Therapeut Inc, Clinton, NJ USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
915
引用
收藏
页码：450 / 450
页数：1
相关论文
共 50 条
  • [21] Optimisation of RPE65 gene delivery for treatment of Leber congenital amaurosis patients
    Georgiadis, T.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [22] RPE65 Mutations in Two Japanese Families with Leber Congenital Amaurosis
    Katagiri, Satoshi
    Hayashi, Takaaki
    Kondo, Mineo
    Tsukitome, Hideyuki
    Yoshitake, Kazutoshi
    Akahori, Masakazu
    Ikeo, Kazuho
    Tsuneoka, Hiroshi
    Iwata, Takeshi
    OPHTHALMIC GENETICS, 2016, 37 (02) : 161 - 169
  • [23] Different functional outcome of RetGC1 and RPE65 gene mutations in Leber congenital amaurosis
    Perrault, I
    Rozet, JM
    Ghazi, I
    Leowski, C
    Bonnemaison, M
    Gerber, S
    Ducroq, D
    Cabot, A
    Souied, E
    Dufier, JL
    Munnich, A
    Kaplan, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (04) : 1225 - 1228
  • [24] Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year
    Cideciyan, Artur V.
    Hauswirth, William W.
    Aleman, Tomas S.
    Kaushal, Shalesh
    Schwartz, Sharon B.
    Boye, Sanford L.
    Windsor, Elizabeth A. M.
    Conlon, Thomas J.
    Sumaroka, Alexander
    Pang, Ji-jing
    Roman, Alejandro J.
    Byrne, Barry J.
    Jacobson, Samuel G.
    HUMAN GENE THERAPY, 2009, 20 (09) : 999 - 1004
  • [25] Gene therapy for RPE65-related Leber congenital amaurosis
    Leroy, B. P.
    ACTA OPHTHALMOLOGICA, 2014, 92
  • [26] Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis
    Stein, Linda
    Roy, Kamolika
    Lei, Lei
    Kaushal, Shalesh
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (03) : 429 - 439
  • [27] Long-term effect of gene therapy on Leber congenital amaurosis caused by defects in RPE65
    Bainbridge, James W. B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [28] Molecular Mechanism and Gene Enhancement Therapy of Leber Congenital Amaurosis Caused by RPE65 Point Mutations in Patient iPSC Derived RPE Cells
    Zhong, Xiufeng
    Ye, Ke
    Zhang, Suai
    Xu, Ping
    Song, Xiaojing
    Wang, Yuan
    MOLECULAR THERAPY, 2024, 32 (04) : 756 - 756
  • [29] Defining the Residual Vision in Leber Congenital Amaurosis Caused by RPE65 Mutations
    Jacobson, Samuel G.
    Aleman, Tomas S.
    Cideciyan, Artur V.
    Roman, Alejandro J.
    Sumaroka, Alexander
    Windsor, Elizabeth A. M.
    Schwartz, Sharon B.
    Heon, Elise
    Stone, Edwin M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (05) : 2368 - 2375
  • [30] RPE65 Mutations May be a Common Cause of Leber Congenital Amaurosis in India
    Gandra, M.
    Natarajan, S. N.
    Khetan, V.
    Arunachalam, J. P.
    Lingam, G.
    Jagadeesan, M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
12345